AI Business

1d ago

Isomorphic Labs Pursues Funding with $40 Billion Valuation

Oct 8, 2026

AI Summary

Isomorphic Labs, a startup focused on AI-driven drug discovery and a spin-off from Google DeepMind, is seeking to raise new funding. The company is reportedly aiming for a valuation of at least $40 billion during this funding round.

Isomorphic Labs is an AI-powered drug discovery startup.
The company is a spin-off from Alphabet Inc.’s Google DeepMind.
It is currently in early discussions to raise new funds.
The targeted valuation for this funding round is at least $40 billion.

fundingdrug discoverystartupvaluationisomorphic labs

Related Stories

OpenAI Revises Revenue Projections, Delta Air Lines Misses Earnings Estimates, and Starbucks Considers Chipotle Acquisition

25m ago

Revolut CEO outlines plans to expand digital banking services in the US

2h ago

Bending Spoons CEO Highlights Acquisition Opportunities Amid Software Valuation Declines

2h ago

AI Competition Shifts Focus to Financing Strategies Amid Technology Developments

3h ago